Severe asthma can be controlled by a monthly injection, trial finds
PositiveWorld Affairs

- A clinical trial has found that a monthly injection of Tezepelumab could enable individuals with severe asthma to reduce or stop their reliance on daily steroid tablets, which are commonly used to manage severe symptoms. This treatment may significantly improve the quality of life for asthmatics who do not respond well to traditional inhalers.
- The implications of this development are substantial, as over 260 million people globally suffer from asthma. If widely adopted, Tezepelumab could transform asthma management, reducing the need for oral corticosteroids and potentially lowering the associated health risks.
— via World Pulse Now AI Editorial System







